However, injectable or systemic use is not approved, and we still lack strong clinical trials in those areas
Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani M-R, Hosseini S-M-R, Yekehtaz H, Tabrizi M, Rezaei F, Salehi B, Sadeghi S-M-H, Moghadam M, Gharibi F, Mirshafiee O:, Akhondzadeh S: N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study
NR protects mice from HFD-induced body weight gain, enhances the liver weight regain by promoting hepatocyte replication and increasing hepatic ATP content in the regenerating liver
10.1016/j.biopha.2023.115752 135 YaS.WenL.Yong-linW.Zi-pengG.QunW.Yong-junL.et al (2019)
Second, dehydration becomes a serious concern